COVAX, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating ... Dec 19
China's Kangtai Biological Products cleared for human trial while Chinese Academy of Medical Sciences vaccine candidate is in mid-stage trial.... Sep 29
To increase manufacturing capacity Inovio partners with Thermo Fisher Scientific... Sep 09
The expansion of partnership is an important step forward in the efforts to develop a safe, effective and globally accessible vaccine against COVID-19... Jul 18
The company tested 40 healthy participants in the Phase 1 trial who were given two shots, four weeks apart, of the vaccine, called INO-4800, ... May 21
-Advertisements-